The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(+)-5-({[6-Bromo-3-methyl-2-(piperidin-1-yl)quinolin-4-yl]carbonyl}amino)-4-(2-chlorophenyl)pentanoic acid ID: ALA4779694
Chembl Id: CHEMBL4779694
PubChem CID: 142451565
Max Phase: Preclinical
Molecular Formula: C27H29BrClN3O3
Molecular Weight: 558.90
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(N2CCCCC2)nc2ccc(Br)cc2c1C(=O)NCC(CCC(=O)O)c1ccccc1Cl
Standard InChI: InChI=1S/C27H29BrClN3O3/c1-17-25(21-15-19(28)10-11-23(21)31-26(17)32-13-5-2-6-14-32)27(35)30-16-18(9-12-24(33)34)20-7-3-4-8-22(20)29/h3-4,7-8,10-11,15,18H,2,5-6,9,12-14,16H2,1H3,(H,30,35)(H,33,34)
Standard InChI Key: NSGXAKNMXJAYCZ-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 558.90Molecular Weight (Monoisotopic): 557.1081AlogP: 6.33#Rotatable Bonds: 8Polar Surface Area: 82.53Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 4.21CX Basic pKa: 3.46CX LogP: 6.20CX LogD: 3.49Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.34Np Likeness Score: -0.86
References 1. Beck H,Thaler T,Meibom D,Meininghaus M,Jörißen H,Dietz L,Terjung C,Bairlein M,von Bühler CJ,Anlauf S,Fürstner C,Stellfeld T,Schneider D,Gericke KM,Buyck T,Lovis K,Münster U,Anlahr J,Kersten E,Levilain G,Marossek V,Kast R. (2020) Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)., 63 (20.0): [PMID:32969660 ] [10.1021/acs.jmedchem.0c00834 ] 2. Beck H,Thaler T,Meibom D,Meininghaus M,Jörißen H,Dietz L,Terjung C,Bairlein M,von Bühler CJ,Anlauf S,Fürstner C,Stellfeld T,Schneider D,Gericke KM,Buyck T,Lovis K,Münster U,Anlahr J,Kersten E,Levilain G,Marossek V,Kast R. (2020) Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)., 63 (20.0): [PMID:32969660 ] [10.1021/acs.jmedchem.0c00834 ]